Tuesday, 02 January 2024 12:17 GMT

China Criticizes US Over COVID-19 Origin Investigation


(MENAFN) Chinese public health officials, according to state media, expressed strong disapproval on Wednesday toward the United States for what they described as a renewed effort to “politicize” the investigation into the origins of COVID-19.

Authorities framed this action as a deliberate strategy to tarnish Beijing’s image.

A representative from China’s National Health Commission denounced the U.S. administration’s approach, arguing that it transforms a matter of scientific inquiry into a political agenda, as reported by the media.

This reaction came shortly after the U.S. government launched a new online platform aimed at outlining the origins of the COVID-19 outbreak. The website includes claims asserting that "the epidemic began in a lab leak in China."

Following this development, China’s Ministry of Foreign Affairs issued a formal response, stating its firm opposition to what it labeled as the U.S.'s political manipulation surrounding the search for the virus's beginnings.

Guo Jiakun, a spokesperson for the Foreign Ministry, addressed journalists, emphasizing that tracing the roots of the virus is a complex and legitimate scientific task.

He highlighted China’s willingness to contribute to international, evidence-driven research efforts, stressing that the country has done so with an attitude of honesty and openness.

Guo also called on the United States to “stop politicizing and weaponizing origins-tracing at once, stop scapegoating others, and stop playing deaf to the questions concerning its role in the pandemic,” urging a more responsible and factual approach to this global issue.

MENAFN24042025000045017167ID1109466656


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Search